The 200,000ft² will accommodate the biologics process science labs, molecular biology lab, molecular characterization, functional bioassay and formulations development lab. An independent quality group at BRC will make
As per the agreement, Millennium will have access to Presage’s technology platform to enable non-clinical identification of effective oncology drug combinations in solid tumors. Presage is eligible to
Par’s initial shipments will comprise generically-labeled presentations of the Provigil product. Modafinil, a wakefulness-prompting agent for oral administration, indicated to improve wakefulness in adult patients with excessive sleepiness
Label update also includes approval of combination therapy with basal insulin for the treatment of adults with type 2 diabetes. The update is based on data from two
One Eleven Software CEO Janet Carlson said the combination of One Eleven’s e-sampling solutions with ROI²’s Sphere of Influence will improve pharmaceutical company targeting of physicians. "Network Sampling
The cross-over randomized PK study enrolled 30 healthy subjects and were given either TNX-102 2.4mg promicellar gelcap or Flexeril 5mg immediate release cyclobenzaprine. The study conducted in Canada
Intermezzo (zolpidem tartrate), which contains a bicarbonate-carbonate buffer, is available in spearmint-flavored sublingual tablets that are placed under the tongue and allowed to disintegrate completely before swallowing. The
The agreement is intended for the manufacture and sale of three anti-ageing products specifically formulated by Phosphagenics for the Indian market. Under the deal, Intas will pay an
The delivery method will provide benefits of cannabinoid-based healthcare research to medical professionals and patients looking for innovative products. The product can be formulated in different dosage levels
Karolinska Institutet will use Advaxis immunotherapies to develop allergy treatments using the models that were developed at Karolinska. Advaxis chairman/CEO Thomas Moore said: "The Karolinska Institutet is a
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.